Table 5. PVZ and SVZ dose correlation with survival.
| Variable | Dose (in Gray) groups | PFS in months | p value (log rank) | OS in months | p value (log rank) |
|---|---|---|---|---|---|
| iSVZ | <58.0 versus ≥58.0 | 12 versus 11 | 0.34 | 13 versus 13 | 0.27 |
| cSVZ | <46.3 versus ≥46.3 | 10 versus 11 | 0.31 | 13 versus 12 | 0.15 |
| bSVZ | <51.4 versus ≥51.4 | 10 versus 11 | 0.56 | 13 versus 12 | 0.33 |
| iPVZ | <57.5 versus ≥57.5 | 12 versus 10 | 0.43 | 15 versus 11 | 0.22 |
| cPVZ | <46.0 versus ≥46.0 | 9 versus 11 | 0.78 | 13 versus 12 | 0.83 |
| bPVZ | <51.0 versus ≥51.0 | 10 versus 11 | 0.98 | 13 versus 12 | 0.38 |
SVZ, subventricular zone; PVZ, periventricular zone; i, ipsilateral; c, contralateral; b, bilateral